The popularity of Viagra initially sparked a period of growth for pharma, but recent shifts present a murky scenario for investors. Off-patent versions are eroding earnings, and continued litigation add further https://emilyhbau235762.glifeblog.com/39824807/viagra-and-the-pharmaceutical-industry-a-precarious-play